HOME > VC DEALS > Merus N.V.
Deal IconDeal

Merus N.V.

Merus acquired by Genmab for €6.8B

Merus N.V., a Utrecht, Netherlands-based oncology-focused biotech company, was acquired for €6.8 billion by Genmab A/S, a Copenhagen, Denmark-based biotechnology firm.

More on SiliconCanals →


ADVERTISEMENT carta_vcd_page_OCFO

Similar Health deals

The VC Industry's trusted resource

Stay informed on industry shifts, deal trends, and career opportunities in venture capital.

Jobs